Pediatric Research
Your donation to the Children's Fund can help support groundbreaking
research at Packard, helping to ensure that children in the Bay Area benefit
from medical discoveries. Research funded through the Children's Fund
include:
- A study to develop more effective treatments for children with juvenile
rheumatoid arthritis.
- Research into the causes of severe and sometimes fatal gastrointestinal
illness in premature infants.
- A study of why some tumor cells are resistant to chemotherapy.

With
the support Children's Fund donors, Joseph DiCarlo, M.D., has developed
a new treatment, called hemofiltration, for patients suffering from Acute
Respiratory Distress Syndrome (ARDS), which is one of the leading causes
of death in pediatric cancer patients. Among the patients who have received
the hemofiltration treatment was 10-year-old Zandalee Springs (right)
who, after battling lymphoma, developed ARDS. She was given only a 50-50
chance of survival until DiCarlo stepped in with his experimental treatment.
A month later, Zandalee was back at school. Thanks to Children's Fund
support, DiCarlo is putting together a consortium of 12 university hospitals
in three countries that will test the new therapy on more than 100 children.
|

|